FOLOTYN DIN 02481820
Health Canada record
| Active ingredient(s) | PRALATREXATE 20 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01BA05 PRALATREXATE% |
| Original market date | 15-Jan-2019 |
| Current status date | 15-Jan-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Servier Canada Inc — licence 100542, currently licensed, last inspection rating C (2023-05-31).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PRALATREXATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02481855 | FOLOTYN | SERVIER CANADA INC | Solution | PRALATREXATE 40 MG | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21458 | 2018-10-26 | New Drug Submission (NDS) |
International API supply for PRALATREXATE
3 active FDA Drug Master Files.
Request a quote for FOLOTYN